Vaxxas Publication in PLoS Medicine Reveals Groundbreaking Clinical Research on Broad Potential of Novel High-Density Microarray Patch (HD-MAP)

17 March 2020

To Effeciently Deliver Vaccines Directly to the Skin, Enhancing Immunogenicity

Read the full media release below.

Learn more

You may also like

18 June 2023

Healthcare

Vaxxas opens world-class manufacturing facility to produce needle-free vaccine patch


06 December 2022

OneVentures

Needle-free vaccine innovator banks $34m


10 November 2021

OneVentures

Vaxxas recognised in the Top 10 healthcare startups in Australia, 2021


View All

Ventured. Gained.
decor